Home > Offer to Sell > Pharmaceuticals and Biochemicals > Antianaphylaxis(antihistamines) and antidotes > Linagliptin
Linagliptin
Inquiry
| Post Date: | Oct 06,2013 |
| Expiry Date: | Oct 06,2014 |
| Detailed Description: |
Cas No. :668270-12-0
Linagliptin is an Inhibitor of dipeptidyl peptidase 4, it is a member of the “Gliptin” class of oral hypoglycemics that block DPP-4. They can be used to treat diabetes mellitus type 2.
Linagliptin was approved by the US FDA in 2011 |
| CAS Registry Number: | 668270-12-0 |
| Synonyms: | ;8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione;8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione;1h-purine-2,6-dione, 8-[(3r)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-; |
| Molecular Formula: | C25H28N8O2 |
| Molecular Weight: | 472.5422 |
| Molecular Structure: | 
|
| Company: | Stereokem [ United States ] |
| Contact: | Sundar |
| Tel: | +1-415-290-0331 |
| Fax: | |
| Email: | gideon@stereokem.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
